Nina DiPrimio, Ph.D.
Affiliations: | 2009 | Pharmacology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Virology BiologyGoogle:
"Nina DiPrimio"Mean distance: 30533.1
Parents
Sign in to add mentorRichard J. Samulski | grad student | 2009 | UNC Chapel Hill | |
(Surface loop dynamics of a parvovirus.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Iyer S, Mast JD, Tsang H, et al. (2019) Drug screens of NGLY1 Deficiency worm and fly models reveal catecholamine, NRF2 and anti-inflammatory pathway activation as potential clinical approaches. Disease Models & Mechanisms |
Lao JP, DiPrimio N, Prangley M, et al. (2018) Yeast Models Of Phosphomannomutase 2 Deficiency, A Congenital Disorder Of Glycosylation. G3 (Bethesda, Md.) |
Granatosky EA, DiPrimio N, Pickering JRE, et al. (2018) GEX1A, a Polyketide from Streptomyces chromofuscus, Corrects the Cellular Defects Associated with Niemann-Pick Type C1 in Human Fibroblasts. Journal of Natural Products |
Xia Y, DiPrimio N, Keppel TR, et al. (2013) The designability of protein switches by chemical rescue of structure: mechanisms of inactivation and reactivation. Journal of the American Chemical Society. 135: 18840-9 |
Li C, Diprimio N, Bowles DE, et al. (2012) Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles. Journal of Virology. 86: 7752-9 |
DiPrimio N, McPhee SW, Samulski RJ. (2010) Adeno-associated virus for the treatment of muscle diseases: toward clinical trials. Current Opinion in Molecular Therapeutics. 12: 553-60 |
Johnson JS, Li C, DiPrimio N, et al. (2010) Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction. Journal of Virology. 84: 8888-902 |
Asokan A, Conway JC, Phillips JL, et al. (2010) Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nature Biotechnology. 28: 79-82 |
Li C, Hirsch M, DiPrimio N, et al. (2009) Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo. Journal of Virology. 83: 6817-24 |
Li W, Asokan A, Wu Z, et al. (2008) Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1252-1260 |